Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Equipment
Datasets
Search by expertise, name or affiliation
Prot #AMV564-101: A Phase 1, First in Human, Open Label, Dose Escalation Study of AMV564, a CD33 x CD3 Tandem Diabody in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Altman, Jessica K
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
10/18/18
→
10/18/21
Funding
Amphivena Therapeutics, Inc.
(Prot #AMV564-101)
View all
View less